Data as of Mar 07
| -0.13 / -0.72%|
The 7 analysts offering 12-month price forecasts for Insmed Inc have a median target of 25.00, with a high estimate of 45.00 and a low estimate of 7.00. The median estimate represents a +39.35% increase from the last price of 17.94.
The current consensus among 7 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.